Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

AUY 954

Known as: AUY-954, AUY954 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
M1/M2 polarization of immune cells including microglia has been well characterized. It mediates detrimental or beneficial roles… Expand
Is this relevant?
2017
2017
Medically relevant roles of receptor-mediated sphingosine 1-phosphate (S1P) signaling have become a successful or promising… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
Signaling through sphingosine-1-phosphate receptor1 (S1P1) promotes blood vessel barrier function. Degradation of S1P1 results in… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2012
2012
There is a need to better understand the mechanism of airway hyper-reactivity, a key feature of asthma. Evidence suggests that… Expand
  • table 1
  • figure 2
  • figure 3
  • table 2
  • figure 5
Is this relevant?
2012
2012
Gradients of the sphingolipid sphingosine-1-phosphate (S1P) are responsible for the egress of lymphocytes from lymph nodes by… Expand
Is this relevant?
Highly Cited
2011
Highly Cited
2011
IntroductionMicroglial activation in multiple sclerosis has been postulated to contribute to long-term neurodegeneration during… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2010
2010
There is no known antiviral drug treatment that routinely terminates persistent virus infections. A recent provocative report… Expand
Is this relevant?
2009
2009
Experimental autoimmune neuritis (EAN) is a T cell-mediated autoimmune inflammatory demyelinating disease of the peripheral… Expand
Is this relevant?
2009
2009
BACKGROUND AND PURPOSE It has been suggested that intratracheal administration of the immunomodulator, FTY720, could have anti… Expand
Is this relevant?
Highly Cited
2006
Highly Cited
2006
FTY720 is an immunomodulator with demonstrated efficacy in a phase II trial of relapsing multiple sclerosis. FTY720-phosphate… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?